Cardiovascular Surgery Without Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia Type II Using Anticoagulation with Recombinant Hirudin
- 1 February 2000
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 90 (2) , 292-298
- https://doi.org/10.1213/00000539-200002000-00010
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Heparin-induced thrombocytopeniaPostgraduate Medicine, 1998
- Development of Argatroban, a Direct Thrombin Inhibitor, and Its Clinical ApplicationSeminars in Thrombosis and Hemostasis, 1997
- Heparin-associated Thrombocytopenia and ThrombosisAnesthesiology, 1997
- Anticoagulation with Novastan®(Argatroban) in Patients with Heparin-Induced Thrombocytopenia and Heparin-Induced Thrombocytopenia and Thrombosis SyndromeSeminars in Thrombosis and Hemostasis, 1997
- Anticoagulation in Patients with Heparin-Induced Thrombocytopenia Type IISeminars in Thrombosis and Hemostasis, 1997
- Rekombinantes Hirudin als Antikoagulans für den kardiopulmonalen Bypass in der Herzchirurgie: Klinische ErfahrungenZeitschrift für Herz-,Thorax- und Gefäßchirurgie, 1997
- Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable systemThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparinless cardiopulmonary bypass with ancrodThe Annals of Thoracic Surgery, 1994
- Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assayTransfusion, 1994
- Heparin‐induced thrombocytopeniaAustralian and New Zealand Journal of Medicine, 1992